Analysts Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) PT at $4.00

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have received an average rating of “Hold” from the four research firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating on the company. The average twelve-month price target among brokers that have covered the stock in the last year is $4.00.

BIOX has been the subject of several research analyst reports. Wall Street Zen downgraded shares of Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research report on Saturday, April 4th. Weiss Ratings upgraded Bioceres Crop Solutions from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, June 26th.

Bioceres Crop Solutions Trading Up 1.7%

Shares of NASDAQ:BIOX opened at $0.34 on Friday. Bioceres Crop Solutions has a 1 year low of $0.31 and a 1 year high of $4.50. The firm has a market capitalization of $21.22 million, a price-to-earnings ratio of -0.09 and a beta of 0.42. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.88 and a quick ratio of 0.70. The business’s 50 day moving average price is $0.41 and its 200-day moving average price is $0.65.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings results on Monday, May 11th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.11). The company had revenue of $39.40 million during the quarter, compared to analysts’ expectations of $54.50 million. Bioceres Crop Solutions had a negative return on equity of 33.97% and a negative net margin of 92.85%. On average, equities research analysts forecast that Bioceres Crop Solutions will post -0.16 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Bank of America Corp DE raised its stake in Bioceres Crop Solutions by 186.7% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after purchasing an additional 3,735 shares during the last quarter. Jones Financial Companies Lllp boosted its stake in Bioceres Crop Solutions by 3,535.8% during the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after purchasing an additional 5,339 shares during the last quarter. PDT Partners LLC grew its holdings in shares of Bioceres Crop Solutions by 58.9% during the second quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after buying an additional 10,449 shares in the last quarter. Virtu Financial LLC purchased a new stake in shares of Bioceres Crop Solutions during the third quarter worth $40,000. Finally, Invesco Ltd. acquired a new stake in shares of Bioceres Crop Solutions in the fourth quarter valued at about $45,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.